CDK5-cyclin B1 regulates mitotic fidelity.
Xiao-Feng ZhengAniruddha SarkarHumphrey LotanaAleem SyedHuy NguyenRichard G IveyJacob J KennedyJeffrey R WhiteakerBartlomiej TomasikKaimeng HuangFeng LiAlan D' AndreaAmanda G PaulovichKavita ShahAlexander SpektorDipanjan ChowdhuryPublished in: Nature (2024)
CDK1 has been known to be the sole cyclin-dependent kinase (CDK) partner of cyclin B1 to drive mitotic progression 1 . Here we demonstrate that CDK5 is active during mitosis and is necessary for maintaining mitotic fidelity. CDK5 is an atypical CDK owing to its high expression in post-mitotic neurons and activation by non-cyclin proteins p35 and p39 2 . Here, using independent chemical genetic approaches, we specifically abrogated CDK5 activity during mitosis, and observed mitotic defects, nuclear atypia and substantial alterations in the mitotic phosphoproteome. Notably, cyclin B1 is a mitotic co-factor of CDK5. Computational modelling, comparison with experimentally derived structures of CDK-cyclin complexes and validation with mutational analysis indicate that CDK5-cyclin B1 can form a functional complex. Disruption of the CDK5-cyclin B1 complex phenocopies CDK5 abrogation in mitosis. Together, our results demonstrate that cyclin B1 partners with both CDK5 and CDK1, and CDK5-cyclin B1 functions as a canonical CDK-cyclin complex to ensure mitotic fidelity.